BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25361009)

  • 1. Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability.
    Park MH; Choi KY; Jung Y; Min do S
    Oncotarget; 2014 Dec; 5(23):11857-72. PubMed ID: 25361009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
    Park MH; Bae SS; Choi KY; Min do S
    Exp Mol Med; 2015 Nov; 47(11):e196. PubMed ID: 26611735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
    Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
    Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pleckstrin homology domain of phospholipase D1 accelerates EGFR endocytosis by increasing the expression of the Rab5 effector, rabaptin-5.
    Park MH; Choi KY; Min do S
    Exp Mol Med; 2015 Dec; 47(12):e200. PubMed ID: 26680696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative regulation of HIF-1α stability through Phosphorylation on Ser451.
    Han HJ; Saeidi S; Kim SJ; Piao JY; Lim S; Guillen-Quispe YN; Choi BY; Surh YJ
    Biochem Biophys Res Commun; 2021 Mar; 545():150-156. PubMed ID: 33550096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
    Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
    Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
    Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
    Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
    Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL
    Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.
    Demidenko ZN; Rapisarda A; Garayoa M; Giannakakou P; Melillo G; Blagosklonny MV
    Oncogene; 2005 Jul; 24(30):4829-38. PubMed ID: 15897903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
    Lee SH; Bae SC; Kim KW; Lee YM
    Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α Hydroxyprolines Modulate Oxygen-Dependent Protein Stability Via Single VHL Interface With Comparable Effect on Ubiquitination Rate.
    He W; Batty-Stuart S; Lee JE; Ohh M
    J Mol Biol; 2021 Nov; 433(22):167244. PubMed ID: 34537235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line.
    Lee K; Kang JE; Park SK; Jin Y; Chung KS; Kim HM; Lee K; Kang MR; Lee MK; Song KB; Yang EG; Lee JJ; Won M
    Biochem Pharmacol; 2010 Oct; 80(7):982-9. PubMed ID: 20599784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
    Flügel D; Görlach A; Michiels C; Kietzmann T
    Mol Cell Biol; 2007 May; 27(9):3253-65. PubMed ID: 17325032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase.
    Li SH; Chun YS; Lim JH; Huang LE; Park JW
    Int J Biochem Cell Biol; 2011 May; 43(5):795-804. PubMed ID: 21316481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein.
    Frost J; Rocha S; Ciulli A
    J Biol Chem; 2021 Aug; 297(2):100910. PubMed ID: 34174286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription.
    Ampofo E; Kietzmann T; Zimmer A; Jakupovic M; Montenarh M; Götz C
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the regulation of hypoxia-inducible factor-1α levels by 2-deoxy-D-ribose.
    Ikeda R; Tabata S; Tajitsu Y; Nishizawa Y; Minami K; Furukawa T; Yamamoto M; Shinsato Y; Akiyama S; Yamada K; Takeda Y
    Oncol Rep; 2013 Sep; 30(3):1444-8. PubMed ID: 23807085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
    Yu F; White SB; Zhao Q; Lee FS
    Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protein Phosphatase PPM1G Destabilizes HIF-1α Expression.
    Pyo J; Ryu J; Kim W; Choi JS; Jeong JW; Kim JE
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.